The joint pain injections market has witnessed significant growth in recent years, owing to the increasing demand for minimally invasive procedures and the rising incidences of joint pain. In this article, we will discuss the regional analysis and key players in the joint pain injections market.
Regional Analysis:
North America dominates the joint pain injections market, owing to the presence of key players in the region and the increasing adoption of minimally invasive procedures. According to a report by Grand View Research, the North America joint pain injections market was valued at USD 1.1 billion in 2020 and is expected to reach USD 1.8 billion by 2027.
Europe is the second-largest market for joint pain injections, owing to the increasing prevalence of joint pain and the growing aging population in the region. According to a report by MarketsandMarkets, the Europe joint pain injections market is expected to grow at a CAGR of 6.3% during the forecast period of 2020-2025.
Asia-Pacific is expected to witness significant growth in the joint pain injections market, owing to the increasing adoption of minimally invasive procedures and the rising geriatric population in the region. According to a report by Fortune Business Insights, the Asia-Pacific joint pain injections market was valued at USD 829.4 million in 2019 and is expected to reach USD 1.6 billion by 2027.
Key Players:
The joint pain injections market is highly competitive, with several key players operating in the market. Some of the key players in the market include Sanofi SA, Pfizer Inc., Anika Therapeutics Inc., Ferring B.V., and Flexion Therapeutics Inc.
Sanofi SA is a leading player in the joint pain injections market, with a strong presence in North America and Europe. The company offers a range of joint pain injections, including Synvisc, which is a hyaluronic acid injection used for the treatment of knee osteoarthritis.
Pfizer Inc. is another major player in the joint pain injections market, with a strong presence in North America and Europe. The company offers a range of joint pain injections, including Celestone Soluspan, which is a corticosteroid injection used for the treatment of joint pain and inflammation.
Anika Therapeutics Inc. is a key player in the joint pain injections market, with a strong presence in North America and Europe. The company offers a range of joint pain injections, including Cingal, which is a combination therapy injection used for the treatment of knee osteoarthritis.
Conclusion:
In conclusion, the joint pain injections market is witnessing significant growth, owing to the increasing demand for minimally invasive procedures and the rising incidences of joint pain. North America dominates the market, followed by Europe and Asia-Pacific. The market is highly competitive, with several key players operating in the market. Sanofi SA, Pfizer Inc., and Anika Therapeutics Inc. are some of the key players in the market.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Everest Market Insights journalist was involved in the writing and production of this article.